Bayer Stands By Iberogast As German Court Investigates Manslaughter Case
Executive Summary
Bayer's Iberogast is in the spotlight in Germany. According to media reports, a German court is investigating a 2018 Iberogast-related death as a possible case of manslaughter and bodily harm caused by negligence. Bayer is standing behind its product, stating that the death was “most probably” due to an “idiosyncratic reaction.”
You may also be interested in...
Bayer Germany Reverse-Switches Phytohustil, Expands Iberogast
Bayer Vital is taking the unusual step to reverse-switch its Phytohustil range of herbal cough medicines in Germany, to strengthen the role of pharmacy in ensuring consumers access the right products for their needs. The company is also launching a new celandine-free addition to its embattled Iberograst brand of herbal gastrointestinal medicines.
Bayer Hopes Consumer Health Woes Are In Rear View Mirror As Business Returns To Growth
Bayer is starting to see green shoots of recovery after a prolonged period of declining sales and earnings at its Consumer Health business. Turnover improved by 2% in the second quarter, driven by gains in Europe and Latin America.
Pascoe offers Iberogast alternative
Natural medicines specialist Pascoe Naturmedizin is positioning in the German market its Pascoventral herbal gastrointestinal liquid as a non-celandine alternative to Bayer Consumer Health’s Iberogast, which has been recently hit by controversy in the country.